About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 7407 record(s)
Req # A-2023-001169
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109561-522.Organization: Health Canada
July 2024
Req # A-2023-001266
Adverse Drug Reactions (ADRs). Report numbers: E2B_00675714, E2B_02977829, E2B_03128456.Organization: Health Canada
July 2024
Req # A-2023-001320
Adverse Drug Reactions (ADRs) for Risedronate-35. Report numbers: 000920421, E2B_02181798. ADRs for Omeprazole-20. Report numbers: 000719460, 000935798, 000982924. ADRs for Pantoprazole-40. Report numbers: 000911912, 000940198, E2B_02784902,…Organization: Health Canada
July 2024
Req # A-2023-001393
Adverse Drug Reaction (ADR) for . Report number: E2B_01195522. ADR for Zenhale. Report number: 000335842.Organization: Health Canada
July 2024
Req # A-2023-001424
Adverse Drug Reaction (ADR) for Tazemetostat. Report number: E2B_06711165.Organization: Health Canada
July 2024
Req # A-2023-001473
Adverse Drug Reactions (ADRs). Report numbers: E2B_ 06770551, E2B_06787144.Organization: Health Canada
July 2024
Req # A-2023-001522
Adverse Drug Reaction (ADR). Report number: E2B_05173067.Organization: Health Canada
July 2024
Req # A-2023-001534
Adverse Drug Reactions (ADRs). Report numbers: 001067388, E2B_06778630, 001066676, 001067290, 001071749, 001071491, E2B_06785278, E2B_06800937.Organization: Health Canada
July 2024
Req # A-2023-001562
Adverse Drug Reactions (ADRs). Report numbers: 001070183, 001070713.Organization: Health Canada
July 2024
Req # A-2023-001575
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-111864-298.Organization: Health Canada
July 2024